Results 251 to 260 of about 929,596 (350)
This study identifies Pirin (PIR), an iron‐binding protein, as a critical ferroptosis suppressor in colorectal cancer through lipid membrane remodeling. PIR, induced by NRF2 during ferroptotic stress, transcriptionally regulates PLA2G4A to shift cellular lipid composition away from ferroptosis‐permissive polyunsaturated phospholipids.
Wei Shi +10 more
wiley +1 more source
Terminology Proposal for Adaptive Particle Therapy Classification and Strategies. [PDF]
Pieter P +7 more
europepmc +1 more source
In vivo optical imaging enhances antibody‐drug conjugate (ADC) optimization by enabling real‐time monitoring of stimulus‐responsive drug behavior. We report n501‐CYMMAF, a ratiometric theranostic with strong target affinity and low‐dose efficacy for ovarian metastasis.
Cheng Li +8 more
wiley +1 more source
Wound Infection After Keloid Excision and Adjuvant Radiotherapy: Two Case Reports and Literature Review. [PDF]
Zhao Q, Wang Y, Li J, Liu C.
europepmc +1 more source
A multifunctional nano immunostimulant is first proposed for efficient tumor immunotherapy. The ER targeted ability, superior ROS production, efficient GSH consumption, coupled with the HIF suppression, jointly arouses ICD/ferroptosis pathways to realize efficient tumor immunotherapy.
Guanhong Guo +14 more
wiley +1 more source
Comparative safety and short-term outcomes of intraoperative radiotherapy versus neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a retrospective study. [PDF]
Gong Z +8 more
europepmc +1 more source
The organic nanozyme IR‐IHpd, which has NIR‐PDT and POD‐like activity, is designed for continuous ROS generation. It is co‐encapsulated with CB‐839 and coated with DC membranes to simultaneously target tumors and T cells. Under NIR irradiation, immunogenic cell death is activated. Concurrently, CB‐839 suppresses ammonia‐induced T lymphocyte death (AITD)
Meng Suo +7 more
wiley +1 more source
Case Report: Early experience with hypoxia-targeted SBRT-based partial tumor irradiation in large and bulky tumors. [PDF]
Penagaricano J, Nakashima JY.
europepmc +1 more source
Investigating radiotherapy's impact on intestinal perforation risk in gastrointestinal tumor patients treated with bevacizumab. [PDF]
He WM, Li WS.
europepmc +1 more source
Understanding the potential of probiotics in oral cancer prevention: a short review on microbial modulation. [PDF]
Rivera C.
europepmc +1 more source

